- Medarex buys GenPharm for $165mm in stock
- Cytel Corp. acquires GlycoGen to enhance cell program
- Genencor nets $135mm in 8mm share IPO
- Genencor, Seattle Genetics develop cancer prodrugs
- Epimmune, Genencor develop vaccines; deal transferred
- Genencor, Johns Hopkins ally in cancer immunotherapies
- Abbott buys BASF's Knoll, pharmaceutical units
- Bristol-Myers Squibb buys DuPont Pharma for $7.8bn
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. email@example.com.
All fields are required.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.